Replies to post #40746 on The TradingEdge

[jxyzobrien]

spain woes
hit futures but bounced 9
doubt real selling

[jxyzobrien]

breath declining but not helping bears
-2.15 is just not bad enough to slam the market down

sideways then new low but no real sellers yet

[jxyzobrien]

Gild
Gilead's purchase of Kite Pharma poised to pay off
Gilead Sciences Inc.'s $11 billion bet on Kite Pharma Inc. is poised to pay off, with the approval Wednesday of Kite's flagship cell-therapy treatment for advanced lymphoma patients.
The therapy, known as a Car-T treatment, uses genetically engineered T-cells to attack the blood cancer. It is the second such therapy to get a regulatory green light, after Novartis AG's (NOVN.EB) Car-T drug Kymriah was approved in late August.

earnings the 26
estimates increasing during the quarter